-+ 0.00%
-+ 0.00%
-+ 0.00%

CVS Health Raises FY2026 GAAP EPS Guidance from $6.24-$6.44 to $6.84-$7.04 vs $6.12 Est

Benzinga·08/05/2026 10:33:01
语音播报
CVS Health (NYSE:CVS) raises FY2026 GAAP EPS guidance from $6.24-$6.44 to $6.84-$7.04 vs $6.12 analyst estimate..